HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: CIR on AHA safety

This article was originally published in The Rose Sheet

Executive Summary

CIR on AHA safety: Cosmetic Ingredient Review Expert Panel to review a draft report on the safety of glycolic and lactic acids and their common salts and simple esters March 5. Review of the draft report was tabled at the panel's Dec. 11 meeting so that panelists could consider additional material presented at that meeting ("The Rose Sheet" Dec. 18, p. 5). FDA said it is currently finalizing its analysis of the same data on the two alpha hydroxy acids and will present it in time for the March 5 meeting. The FDA document includes an analysis of adverse reaction data gathered by the agency...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel